Search results for “Chronic pyonephrosis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 135 patents, we discovered top 51 key players by total patent application. Eisai Co., Ltd., Procter & Gamble Co., Melinta Therapeutics, Inc. are dominant in this area. They take 20.00% of the total patent filing.
Eisai Co., Ltd.
Tokyo-to, Japan
Patent: 19
Procter & Gamble Co.
Ohio, United States
Patent: 5
Melinta Therapeutics, Inc.
Connecticut, United States
Patent: 3
Guizhou Warmen Pharmaceutical Co., Ltd.
Guizhou Sheng, China
Patent: 3
SelectImmune Pharma AB
Sweden
Patent: 3
Rempex Pharmaceuticals, Inc.
California, United States
Patent: 3
ID Genomics SPC
Washington, United States
Patent: 3
Chengdu Lvdi Technology Co., Ltd.
Sichuan Sheng, China
Patent: 3
MerLion Pharmaceuticals Pte Ltd.
Central Region, Singapore
Patent: 2
Damavand Wound AB
Sweden
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 8 most active companies in this area. The fast-growing Rempex Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Foshan Ruijian Sports Equipment Co., Ltd. take 33.33% of patent filing during this period.
Rempex Pharmaceuticals, Inc.
California, United States
Patent: 3
Melinta Therapeutics, Inc.
Connecticut, United States
Patent: 3
Foshan Ruijian Sports Equipment Co., Ltd.
Guangdong Sheng, China
Patent: 1
Henan Bainian Kangxin Pharmaceutical Co., Ltd.
Henan Sheng, China
Patent: 1
Kharkiv National Medical University
Ukraine
Patent: 1
ID Genomics SPC
Washington, United States
Patent: 1
Chongqing Yuelong Biopharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 1
Hanshou County Xinyuntang Pharmaceutical Technology Co., Ltd.
Hunan Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 6 new entrants. Rempex Pharmaceuticals, Inc., Melinta Therapeutics, Inc., Foshan Ruijian Sports Equipment Co., Ltd. are the most active new entrants in this area.
Rempex Pharmaceuticals, Inc.
California, United States
Patent: 3
Melinta Therapeutics, Inc.
Connecticut, United States
Patent: 3
Foshan Ruijian Sports Equipment Co., Ltd.
Guangdong Sheng, China
Patent: 1
Henan Bainian Kangxin Pharmaceutical Co., Ltd.
Henan Sheng, China
Patent: 1
Chongqing Yuelong Biopharmaceutical Co., Ltd.
Chongqing Shi, China
Patent: 1
Hanshou County Xinyuntang Pharmaceutical Technology Co., Ltd.
Hunan Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 102 patents, we discovered top 9 universities and scientific research institutions by total patent application. Kharkiv National Medical University, Shanxi Medical University, Tohoku University are dominant in this area. They take 16.67% of the total patent filing.
Kharkiv National Medical University
Ukraine
Patent: 5
Shanxi Medical University
Shanxi Sheng, China
Patent: 4
Tohoku University
Miyagi-ken, Japan
Patent: 3
Peoples' Friendship University of Russia
undefined undefined
Patent: 2
Odessa National Medical University
Ukraine
Patent: 2
Sun Yat-Sen University
Guangdong Sheng, China
Patent: 1
The University of the Basque Country
Spain
Patent: 1
Feng Chia University
Taiwan Province, China
Patent: 1
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: